Flotation

DuoLingo brings in $521m IPO
CapitalG sold $36.3m of shares in an upsized offering for the language learning app developer, which saw its shares rise 36% on their first day.
Outbrain counts up $160m in IPO
The Gruner + Jahr and Susquehanna International Group-backed content recommendation engine developer floated below its range but is slightly up from its IPO price.
Kaltura cashes $150m in IPO
The Mitsui and Intel-backed video software developer has a market capitalisation of almos $1.5bn following its initial public offering last week.
AbSci nabs $200m in initial public offering
AGC, JSR Life Sciences and Merck & Co all scored exits as the synthetic biology technology developer floated on Nasdaq, whose valuation reportedly stands at nearly $2bn.
VTex veers to $361m IPO
The SoftBank-backed e-commerce services platform developer listed on the New York Stock Exchange, pricing the shares above their range.
Caribou Biosciences careers on to public markets
The Corteva, Novartis, AbbVie and Heritage Medical Systems-backed cancer therapy developer priced a $304m initial public offering at the top of its range.
Couchbase sits pretty in $200m IPO
Docomo Capital-backed database software provider Couchbase floated above its range in an offering following some $250m in venture funding.
Dook Media reads A-okay for IPO
The Legend Capital-backed paper and digital book publisher has listed on SZSE’s ChiNext market having raised $9.6m.

Other News

CloudWalk gets the nod for IPO
The Bohai, Haier and PCI-Suntek-backed facial recognition technology developer has been approved to float on Shanghai’s Star Market in a $574m offering.
Bukalapak books in $1.5bn initial public offering
The Emtek, Naver, Microsoft, Gree and Aucfan-backed e-commerce platform developer is set to float in Indonesia at a reported $6bn valuation.
Blend Labs lands on NYSE in $360m IPO
The Salesforce-backed banking software producer floated at the top of its range and saw its shares rise on their first day of trading.
TScan takes in $100m through IPO
The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.
Imago BioSciences bags $134m in upsized IPO
Pharmaron, Celgene, Amgen and Merck & Co-backed Imago BioSciences floated in an IPO today, alongside a private placement transaction featuring Pfizer.
Zomato sets out $1.25bn IPO
The Ant Group, Info Edge and Delivery Hero-backed restaurant listings and food delivery app operator is floating in a dual listing, having secured $562m from anchor investors yesterday.

Editor's Picks

TScan takes in $100m through IPO
The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.
Zomato sets out $1.25bn IPO
The Ant Group, Info Edge and Delivery Hero-backed restaurant listings and food delivery app operator is floating in a dual listing, having secured $562m from anchor investors yesterday.
Didi crashes on to NYSE in $4.4bn IPO
SoftBank, Uber and Tencent are the largest external shareholders of the on-demand ride service, which has floated in an upsized $4.44bn offering.
SentinelOne sends itself to public markets
The Qualcomm Ventures and Samsung Ventures-backed XDR cybersecurity platform developer is going public in an offering sized above $1.22bn.
test reg

Login

Not yet subscribed?

See your subscription offers here